Minefield!Minefield!These 5 companies suddenly announced negative announcements over the weekend, an

Mondo Social Updated on 2024-01-29

[The Shanghai Stock Exchange will focus on monitoring risk warnings this week**].

This week, the Shanghai Stock Exchange will focus on monitoring risk alerts**, such as *ST Tongda, as well as serious abnormal fluctuations**, such as Dongan Power. We will also pay attention to the individual ** with abnormal recent rises and falls.

Hongqi Chain: The change of control is still in the discussion stage **continue to be suspended].

Hongqi Chain (002697) announced on the evening of December 15 that the company's change of control is still in the stage of further discussion. As a result, the company** will continue to suspend trading from Monday, December 18, and the suspension period is expected to be 3 trading days.

Fulai New Materials is concerned about the concept of listing the company as a "sensor".

Fulai New Materials is concerned about the concept of listing the company as a "sensor".The company's main business includes advertising inkjet printing materials, label printing materials, electronic grade functional materials, new film materials, adhesive materials and other industrial consumer goods and high-end intelligent equipment. At present, the company has not received revenue and profit from the business related to "sensors".

Shu Taishen: Xiangtang Group intends to **no more than 1%].

Shutaishen (**002572) announced that the company's shareholder Xiangtang Group plans to ** no more than 1% of the shares. Xiangtang Group is an important shareholder of the company, and will still hold a large proportion of the company's shares in the future. According to the announcement, Xiangtang Group intends to conduct centralized bidding transactions or block transactions of **shares, and the number of **shares does not exceed 1% of the company's total share capital. This ** will not have a significant impact on the control of the company. Shutaishen is a pharmaceutical company focusing on the field of chronic diseases, mainly engaged in independent research and development, production and sales of drugs. The company has a number of intellectual property rights and core technologies, and its products are widely used in cardiovascular, digestive system, nervous system and other fields. This ** may be part of the adjustment of asset allocation of Xiangtang Group, and the specific reason was not disclosed in the announcement. Investors need to keep an eye on the company's subsequent announcements to be aware of the relevant progress.

Shiming Technology: The actual controller intends to 25.9 billion yuan transfer company 681% stake].

Shiming Technology (300522) announced on the evening of December 15 that in order to introduce strategic investors, optimize the equity structure, effectively improve the financial structure of the actual controller, and reduce financial risks such as pledges, the company's controlling shareholder and actual controller Lv Shiming signed a share transfer agreement with Jiangsu Fenghui New Energy Development. According to the agreement, Lu Shiming intends to pay 11$8 ** transfer of its holdings of the company's unrestricted tradable shares 2197470,000 shares, accounting for 681%, and the total transfer price is about 25.9 billion yuan.

Related Pages